Chymase activates promatrix metalloproteinase-9 in human abdominal aortic aneurysm

Clinica Chimica Acta

Volumn 388, Issue 1-2, 2008, Pages 214-216

  Furubayashi, Keiichi ^a   Takai, Shinji ^a   Jin, Denan ^a   Inagaki, Sachiko ^b   Kimura, Maki ^b   Nishimoto, Masayoshi ^a   Fukumoto, Hitoshi ^a   Tanaka, Kazuhiko ^b   Katsumata, Takahiro ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; GELATINASE B; N [1 BENZYL 2,3 DIOXO 6 (2 PYRIDYLOXY)HEXYL] 2 (5 FORMYLAMINO 1,6 DIHYDRO 6 OXO 2 PHENYL 1 PYRIMIDINYL)ACETAMIDE;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANALYSIS OF VARIANCE; CLINICAL ARTICLE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PURIFICATION; FISHER EXACT TEST; HEMODYNAMIC STRESS; HUMAN; LETTER; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AORTIC ANEURYSM, ABDOMINAL; CHYMASES; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED;

EID: 37249007305     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.10.004     Document Type: Letter

References (18)

1. Thompson R.W., Holmes D.R., Mertens R.A., et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 96 (1995) 318-326
2. McMillan W.D., Tamarina N.A., Cipollone M., Johnson D.A., Parker M.A., and Pearce W.H. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation 96 (1997) 2228-2232
3. Freestone T., Turner R.J., Coady A., Higman D.J., Greenhalgh R.M., and Powell J.T. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc. Biol 15 (1995) 1145-1151
4. Pyo R., Lee J.K., Shipley J.M., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 105 (2000) 1641-1649
5. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., and Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110 (2002) 625-632
6. Sluijter J.P., de Kleijn D.P., and Pasterkamp G. Vascular remodeling and protease inhibition-bench to bedside. Cardiovasc Res 69 (2006) 595-603
7. Hobeika M.J., Thompson R.W., Muhs B.E., Brooks P.C., and Gagne P.J. Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg 45 (2007) 849-857
8. Tsuruda T., Kato J., Hatakeyama K., et al. Adrenomedullin in mast cells of abdominal aortic aneurysm. Cardiovasc Res 70 (2006) 158-164
9. 92 bonds of the catalytic domain. J Biol Chem 272 (1997) 25628-25635
10. Nishimoto M., Takai S., Fukumoto H., et al. Increased local angiotensin II formation in aneurysmal aorta. Life Sci 71 (2002) 2195-2205
11. Tsunemi K., Takai S., Nishimoto M., et al. Possible roles of angiotensin II-forming enzymes, angiotensin converting enzyme and chymase-like enzyme, in the human aneurysmal aorta. Hypertens Res 25 (2002) 817-822
12. Takai S., Shiota N., Sakaguchi M., Muraguchi H., Matsumura E., and Miyazaki M. Characterization of chymase from human vascular tissues. Clin Chim Acta 265 (1997) 13-20
13. Takai S., Jin D., Nishimoto M., et al. Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein. Life Sci 69 (2001) 1725-1732
14. Takai S., and Miyazaki M. Application of a chymase inhibitor, NK3201, for prevention of vascular proliferation. Cardiovasc Drug Rev 21 (2003) 185-198
15. Furubayashi K., Takai S., Jin D., et al. The significance of chymase in the progression of abdominal aortic aneurysms in dogs. Hypertens Res 30 (2007) 349-357
16. Shapiro S.D., Fliszar C.J., Broekelmann T.J., Mecham R.P., Senior R.M., and Welgus H.G. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J Biol Chem 270 (1995) 6351-6356
17. Okada Y., Gonoji Y., Naka K., et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267 (1992) 21712-21719
18. Tchougounova E., Lundequist A., Fajardo I., Winberg J.O., Abrink M., and Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 280 (2005) 9291-9296